Ceo
CurrentI am a co-founder and the CEO of Reglagene. We specialize in the discovery and development of new orally administered therapies for the treatment of brain diseases. I have spent my career at the intersection of science and business. My passion for developing new treatments for patients with life-threatening disorders was sparked early on in my academic training, where I completed a PhD in Organic Chemistry from the University of Texas.After completing my degree, I worked as a postdoctoral fellow at the University of California at Berkeley, where I gained hands-on experience in Bioorganic Chemistry. This experience led me to join a leading pharmaceutical company, where I worked on several successful drug development programs across multiple therapeutic areas.With a deep understanding of the science and business of drug development, I co-founded Reglagene, with a vision of developing innovative therapies for patients suffering from brain diseases, the therapeutic sector in greatest need of innovation. In my role as CEO, I lead a team of scientists and business professionals, overseeing the company's research and development activities, as well as its strategic partnerships and fundraising efforts.Under my leadership, the company has made significant progress towards developing new treatments for a range of brain diseases, including primary and secondary brain cancers and Parkinson's disease. Our focus on oral therapies has the potential to revolutionize the treatment of these disorders, making it easier and more convenient for patients to receive the care they need.Overall, my experience as a scientist and entrepreneur has prepared me well for the challenges of leading a biotech company. I am passionate about developing new therapies for brain diseases and am committed to making a positive impact on the lives of patients and their families.